Literature DB >> 17322525

Management of patients with non-ischaemic cardiomyopathy.

Audrey H Wu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17322525      PMCID： PMC1861466          DOI： 10.1136/hrt.2005.085761

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

1.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Authors:  M Packer; P A Poole-Wilson; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; L Rydén; K Thygesen; B F Uretsky
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

2.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

3.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

4.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

5.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors:  John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

6.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Authors:  Christopher B Granger; John J V McMurray; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Marc A Pfeffer; Karl Swedberg
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

7.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

8.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

9.  The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients.

Authors:  E K Kasper; W R Agema; G M Hutchins; J W Deckers; J M Hare; K L Baughman
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

10.  Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure.

Authors:  G Y Xie; M R Berk; M D Smith; J C Gurley; A N DeMaria
Journal:  J Am Coll Cardiol       Date:  1994-07       Impact factor: 24.094
View more
  13 in total

Review 1.  Arrhythmogenic Inflammatory Cardiomyopathy: A Review.

Authors:  Brenton S Bauer; Anthony Li; Jason S Bradfield
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

Review 2.  Transformational Applications of Human Cardiac Organoids in Cardiovascular Diseases.

Authors:  Wanling Xuan; Srinivas M Tipparaju; Muhammad Ashraf
Journal:  Front Cell Dev Biol       Date:  2022-06-09

3.  Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis.

Authors:  Joseph Yeboah; Carlos J Rodriguez; Waqas Qureshi; Songtao Liu; J Jeffrey Carr; Joao A Lima; W Gregory Hundley; David M Herrington
Journal:  J Card Fail       Date:  2016-03-30       Impact factor: 5.712

Review 4.  Passive ventricular remodeling in cardiac disease: focus on heterogeneity.

Authors:  Elise L Kessler; Mohamed Boulaksil; Harold V M van Rijen; Marc A Vos; Toon A B van Veen
Journal:  Front Physiol       Date:  2014-12-22       Impact factor: 4.566

5.  Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?

Authors:  Gaurav S Gulsin; Abishek Shetye; Jeffrey Khoo; Daniel J Swarbrick; Eylem Levelt; Florence Y Lai; Iain B Squire; Jayanth R Arnold; Gerry P McCann
Journal:  BMC Cardiovasc Disord       Date:  2017-04-08       Impact factor: 2.298

6.  Anesthesia Management in a Patient with Unclassified Cardiomyopathy for Transureteral Lithotripsy Surgery.

Authors:  Payman Rezagholi; Arvin Barzanji; Aida Lahorpoor
Journal:  Adv Biomed Res       Date:  2020-09-30

7.  Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.

Authors:  Zyad T Saleh; Ahmad T Alraoush; Ahmad A Aqel; Tagreed O Shawashi; Misook Chung; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2021-07-06       Impact factor: 2.083

8.  The contemporary trends and geographic variation in premature mortality due to heart failure from 1999 to 2018 in the United States.

Authors:  Ali Raza Ghani; Mohsin Sheraz Mughal; Sundeep Kumar; Sara Aslam; Mahboob Alam; Mohammed Haris Usman; Deanna Mikhalkova
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-07

9.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

10.  Ventricular arrhythmias in nonischemic cardiomyopathy.

Authors:  Fa-Po Chung; Chin-Yu Lin; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tze-Fan Chao; Jo-Nan Liao; Yao-Ting Chang; Ting-Yung Chang; Chung-Hsing Lin; Abigail Louise D Te; Shinya Yamada; Shih-Ann Chen
Journal:  J Arrhythm       Date:  2018-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.